Computational Biology Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Research and Development in the Field of Technology – The increasing implementation of artificial intelligence and other network models to develop human brains, and study various organ anatomy is fueling the market growth. For instance, Human Genome Project is one such use of artificial technology in biology.
- Increasing Demand for Personalized Medicines – The applications for personalized medicine in targeted therapies for the treatment of cancer tumors and to treat patients with allergies, organ dysfunction, and vulnerable disease states will boost the computational biology market expansion.
- Growing Drug Discovery Owing to the Incidence of Diseases such as COVID-19 – The rising requirement to treat untreatable diseases and the occurrence of new diseases, to reduce the cost of medicines, and prevent drug resistance is propelling the growth of drug discovery and thereby the use of computational biology.
Challenges
- Dearth of Skilled Personnel – The dearth of experienced and skilled professionals is estimated to hamper the computational biology market growth. The discovery of drugs in computational biology needs the knowledge of pharmaceuticals, pharmacology, and technological advancements. Specialized doctors and clinical research personnel as required to perform computational analytics.
- Presence of Complications
- High Investment Cost and Maintenance Price
Computational Biology Market: Key Insights
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
20.1% |
Base Year Market Size (2024) |
USD 9.42 billion |
Forecast Year Market Size (2037) |
USD 101.88 billion |
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Computational Biology Market in 2025 is assessed at USD 10.93 billion.
The global market size was valued at over USD 9.42 billion in 2024 and is expected to expand at a CAGR of around 20.1%, surpassing USD 101.88 billion revenue by 2037.
North America is poised to secure largest share by 2037, attributed to growing R&D activities and high investment in research activities.
The major players in the market include Dassault Systèmes SE, Certara Inc., Instem Group, Compugen, Chemical Computing Group ULC, Rhenovia Pharma SAS, Nimbus Discovery LLC, Insilico Biotechnology AG, Genedata AG.